Works by Ning, Yang-Min

Results: 11

Reversal of Docetaxel Resistance With Bevacizumab and Thalidomide.

Published in:

Clinical Genitourinary Cancer, 2009, v. 7, n. 2, p. E37, doi. 10.3816/CGC.2009.n.020

By:

Ning, Yang-min;
Figg, William D.;
Dahut, William L.

Publication type:

Article

Acute aortic dissection in a hypertensive patient with prostate cancer undergoing chemotherapy containing bevacizumab.

Published in:

Acta Oncologica, 2008, v. 47, n. 8, p. 1600, doi. 10.1080/02841860801978905

By:

Aragon-Ching, Jeanny B.;
Ning, Yang-Min;
Dahut, William L.

Publication type:

Article

Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.

Published in:

Cancer (0008543X), 2014, v. 120, n. 19, p. 3025, doi. 10.1002/cncr.28809

By:

Wissing, Michel D.;
Kluetz, Paul G.;
Ning, Yang‐Min;
Bull, Jonca;
Merenda, Christine;
Murgo, Anthony J.;
Pazdur, Richard

Publication type:

Article

Accelerated Approval of Oncology Products: The Food and Drug Administration Experience.

Published in:

JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 8, p. 636, doi. 10.1093/jnci/djr062

By:

Johnson, John R.;
Ning, Yang-Min;
Farrell, Ann;
Justice, Robert;
Keegan, Patricia;
Pazdur, Richard

Publication type:

Article

Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer.

Published in:

BJU International, 2016, v. 118, n. 4, p. 590, doi. 10.1111/bju.13412

By:

Madan, Ravi A.;
Karzai, Fatima H.;
Ning, Yang‐Min;
Adesunloye, Bamidele A.;
Huang, Xuan;
Harold, Nancy;
Couvillon, Anna;
Chun, Guinevere;
Cordes, Lisa;
Sissung, Tristan;
Beedie, Shaunna L.;
Dawson, Nancy A.;
Theoret, Marc R.;
McLeod, David G.;
Rosner, Inger;
Trepel, Jane B.;
Lee, Min‐Jung;
Tomita, Yusuke;
Lee, Sunmin;
Chen, Clara

Publication type:

Article

Higher Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Anti-Angiogenic Agents.

Published in:

Cancer Investigation, 2009, v. 27, n. 2, p. 221, doi. 10.1080/07357900802208608

By:

Aragon-Ching, Jeanny B.;
Ning, Yang-Min;
Chen, Clara C.;
Latham, Lea;
Guadagnini, Jean-Pierre;
Gulley, James L.;
Arlen, Philip M.;
Wright, John J.;
Parnes, Howard;
Figg, William D.;
Dahut, William L.

Publication type:

Article

FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA‐Mutated Metastatic Castrate‐Resistant Prostate Cancer.

Published in:

Oncologist, 2021, v. 26, n. 2, p. 139, doi. 10.1002/onco.13585

By:

Anscher, Mitchell S.;
Chang, Elaine;
Gao, Xin;
Gong, Yutao;
Weinstock, Chana;
Bloomquist, Erik;
Adeniyi, Oluseyi;
Charlab, Rosane;
Zimmerman, Sarah;
Serlemitsos‐Day, Maritsa;
Ning, Yang Min;
Mayrosh, Ruth;
Fuller, Barbara;
Trentacosti, Ann Marie;
Gallagher, Pamela;
Bijwaard, Karen;
Philip, Reena;
Ghosh, Soma;
Fahnbulleh, Frances;
Diggs, Felicia

Publication type:

Article

FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin‐Containing Chemotherapy.

Published in:

Oncologist, 2019, v. 24, n. 4, p. 563, doi. 10.1634/theoncologist.2018-0084

By:

Suzman, Daniel L.;
Agrawal, Sundeep;
Ning, Yang‐min;
Maher, V. Ellen;
Fernandes, Laura L.;
Karuri, Stella;
Tang, Shenghui;
Sridhara, Rajeshwari;
Schroeder, Jason;
Goldberg, Kirsten B.;
Ibrahim, Amna;
McKee, Amy E.;
Pazdur, Richard;
Beaver, Julia A.

Publication type:

Article

Accelerating Early Access to Immunotherapies for Advanced Urothelial Carcinoma.

Published in:

2018

By:

Ning, Yang‐Min;
Maher, V. Ellen;
Beaver, Julia A.;
Goldberg, Kirsten B.;
Blumenthal, Gideon M.;
Pazdur, Richard

Publication type:

Editorial

FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum-Containing Chemotherapy.

Published in:

Oncologist, 2017, v. 22, n. 6, p. 743, doi. 10.1634/theoncologist.2017-0087

By:

Ning, Yang‐Min;
Suzman, Daniel;
Maher, V. Ellen;
Zhang, Lijun;
Tang, Shenghui;
Ricks, Tiffany;
Palmby, Todd;
Fu, Wentao;
Liu, Qi;
Goldberg, Kirsten B.;
Kim, Geoffrey;
Pazdur, Richard

Publication type:

Article

U.S. Food and Drug Administration Approval Summary: Enzalutamide for the Treatment of Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer.

Published in:

Oncologist, 2015, v. 20, n. 8, p. 960, doi. 10.1634/theoncologist.2015-0166

By:

Ning, Yang‐Min;
Brave, Michael;
Maher, V. Ellen;
Zhang, Lijun;
Tang, Shenghui;
Sridhara, Rajeshwari;
Kim, Geoffrey;
Ibrahim, Amna;
Pazdur, Richard

Publication type:

Article